Elanco Animal Health Incorporated (ELAN) Stock Analysis
A live, multi-source view of Elanco Animal Health Incorporated (ELAN): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Elanco Animal Health Incorporated
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry.
Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic · United States · 9,400 employees · elanco.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Elanco Animal Health Incorporated (ELAN) had a market capitalization of $12.24B (forward 19.1) and a beta of 1.68; the shares traded in a 52-week range of $18.22 – $27.98 (28.6% over the year).
- Market cap
- $12.24B
- Enterprise value
- $15.94B
- Forward P/E
- 19.1
- PEG ratio
- 4.04
- Price / book
- 1.86
- EPS (trailing)
- $-0.41
- EPS (forward)
- $1.28
- Payout ratio
- 0.0%
- 52-week range
- $18.22 – $27.98
- 52-week change
- 28.6%
- Beta
- 1.68
- Average volume
- 6.0M
- Shares outstanding
- 499.4M
- Short % of float
- 9.45%
- Profit margin
- -4.0%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Elanco Animal Health Incorporated (ELAN) last closed at $22.86 (the last completed close before that scan).
Technicals at the scan: RSI 39 (neutral territory), price -4.8% versus its 20-day average, 20-day versus 50-day average spread -2.2%, MACD histogram -0.08.
Sentiment inputs: 100% of recent Finnhub-scored headlines read bullish; StockTwits 100% bullish; analyst consensus score 78/100.
Next scheduled company event: in 56 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of ELAN; corporate insiders filed 5 buys and 0 sells (5 distinct filers, latest disclosure 2026-08-21). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Lawrence Erik Kurzius (1B/0S), Shiv O'neill (1B/0S), Michael J. Harrington (1B/0S), Paul Herendeen (1B/0S), Robert M. Vanhimbergen (1B/0S). Who is trading what
RapidTradeView pick record
ELAN has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Elanco Animal Health Incorporated (ELAN) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell ELAN.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.